Rein Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.04

+0.07 (+7.08%)

As of Jun 29, 10:32 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +4,414.4% upside

Low Target $33.28

Average Target $46.95

High Target $64.49

Current Price $1.04

Current
$1.04

Target
$46.95

$33.28 $46.95 avg $64.49

Scenario Analysis

Bear Case

$33.28

3,100.0%

Low target

Base Case

$46.95

+4,414.4%

Avg target

Bull Case

$64.49

+6,101.0%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$2.18

-52.3% from high

52-Week Low

$0.86

+20.4% from low

Target vs 52W High

$46.95

+2,053.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%